Then, they selected eight DEPs, namely SRP14, ITGB5, POSTN, SRPX, FHL1, PPP2R4, CPN2, and GPS1, with elevated expression in either phenotype of patients and validated them by ELISA on sera samples donated by another group of patients (15 individuals with psoriatic arthritis and 33—without it). This evidence concerns the gene ITGB5 and psoriatic arthritis.